Catalyst Wire Dossier Catalyst Wire Dossier

DCN01

· Deacon Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCN01, covering 2016-02-11 to 2016-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers [Phase 2]

See pricing